The factory manufactures vaccines to ship to all countries outside of the U.S., according to the German Health Ministry. The renovations are meant to expand the drugmaker’s production capacity after mid-February.
“As part of the normal productivity improvements to increase capacity, we must make modifications to the process and facility that will require additional regulatory approvals,” a Pfizer spokesperson said in a statement. “Although this will temporarily impact shipments in late January to early February, it will provide a significant increase in doses available for patients in late February and March.”
More articles on pharmacy:
Novant Health launches 6 vaccination sites in North Carolina
10% of rural Texas hospitals haven’t received any COVID-19 vaccine doses
J&J vaccine shows some immunity after single dose
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.